Abstract 4364741: Real-world assessment of the efficacy of inclisiran in lowering low-density lipoprotein cholesterol: Outcomes from AAH tertiary cardiovascular clinics

Authors

Prabhjot Hundal, Advocate Health - MidwestFollow
Niloufar Javadi, Advocate Health - MidwestFollow
Kirandeep Kaur
Jim Kanani, Advocate Health - MidwestFollow
Sara Walczak, Advocate Health - MidwestFollow
Venkateswara Gogineni, Advocate Health - MidwestFollow
Eric Weiss, Advocate Health - MidwestFollow
John Crouch, Advocate Health - MidwestFollow
Suhail Allaqaband, Advocate Health - MidwestFollow
Tanvir Bajwa, Advocate Health - MidwestFollow
Patrycja Galazka, Advocate Health - MidwestFollow
A Jamil Tajik, Advocate Health - MidwestFollow
M Fuad Jan, Advocate Health - MidwestFollow

Recommended Citation

Hundal P, Javadi N, Kaur K, et al. Abstract 4364741: Real-World Assessment of the Efficacy of Inclisiran in Lowering Low-Density Lipoprotein Cholesterol: Outcomes From AAH Tertiary Cardiovascular Clinics. Circulation. 2025;152(Suppl_3):A4364741-A4364741. doi:10.1161/circ.152.suppl_3.4364741

Affiliations

Aurora Sinai/Aurora St. Luke's Medical Centers

Type

Abstract